Search

1202253
1202250
1231066
1230827
1202252
Informatics and Visualisation
Glycoinformatics | Bioinformatics | Structural Biology | Cheminformatics | Visual Analytics
Computation and Modelling
QM/MM Computations | Free Energy Computations | Coarse Grain Computations | Molecular Modelling | Ionic Liquid Property Design
Accelerated Code for Life Science Applications
GPU Hardware acceleration | InfiniBand CPU clusters
Glycoenzyme Kinetics
Synthesis | High Throughput Screening | Glycoenzyme Assays | Computational Design | Kinetics
Cancer Translational Science Laboratory
Glycobiology | Next Generation Antimicrobials | Cancer

News

Thursday, 13 December 2018
SCILS 2018: Focus Topic - Bioinformatics

The 2018 Scientific Computing International Lecture Series (SCILS) visiting scholar will be Dr Niclas Karlsson (PI of Glyco Inflammatory Group at the University of Gothenburg, Sweden) 

Dr Karlsson a Glycobioinformatician will present a departmental lecture titled "Osteoarthritis - A life science glycoproblem".

Dr Karlsson is the PI on the UniCarb-DB  database that stores, integrates and processes data from manually annotated ms spectra  glyco fragments. 

 

Publication Date:
Wed, 26 Sep 2018 - 13:30
Molecular Dynamics using BRIDGE

The Scientific Computing Research Unit will be a hosting a workshop – “Molecular Dynamics using BRIDGE” at the 2018 CHPC National Conference. This will take place on the 6th December at the Century City Convention Centre. For more info see http://bit.ly/2C4ybCW. Please register online and on the CHPC registration page:

Hope to see you there! Tweet to us at @scicompute with the #bridge #galaxy #chpc2018 hashtags.

Publication Date:
Wed, 26 Sep 2018 - 13:15
Attendance at Indaba9

INDABA 9 

Sunday, 02 September 2018 - Friday, 07 September 2018

Presenting at the INDABA 9 Conference

Prof Kevin Naidoo - Multidimensional Reaction Dynamics of Enzyme Catalysis Dr Chris Barnett - Computational Cancer Glycobiology: Simulation, Analysis and Visualisation
Publication Date:
Sun, 02 Sep 2018 - 16:00
A first-of-its-kind cancer treatment

BXQ-350 is a first-of-its-kind cancer treatment that weaponizes the special mechanics of cancer to destroy it. Discovered by Xiaoyang Qi - Professor of Medicine, Co-Division Chief for Basic Science Research - BXQ-350 is a protein which can fuse to the walls of cancerous cells, causing those cells to die off.

The news article and publication are available.

Publication Date:
Fri, 10 Aug 2018 - 16:00

Pages